{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:51:40Z","timestamp":1776185500415,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Neurological and Psychiatric Disorders of NCNP","award":["Intramural Research Grant (26-8)"],"award-info":[{"award-number":["Intramural Research Grant (26-8)"]}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","award":["H26-sinkeikinn-ippan-004"],"award-info":[{"award-number":["H26-sinkeikinn-ippan-004"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Grant-in-Aid from the MHLW of Japan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbrc.2015.04.035","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T02:49:25Z","timestamp":1429238965000},"page":"481-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes"],"prefix":"10.1016","volume":"461","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-8030","authenticated-orcid":false,"given":"Shoin","family":"Tei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshige T.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Ishiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.04.035_bib1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/WCO.0000000000000134","article-title":"Congenital myasthenic syndromes and the neuromuscular junction","volume":"27","author":"Cruz","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","article-title":"Current status of the congenital myasthenic syndromes","volume":"22","author":"Engel","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbrc.2015.04.035_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrc.2015.04.035_bib4","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/j.1460-2075.1990.tb07378.x","article-title":"The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon","volume":"9","author":"Beeson","year":"1990","journal-title":"EMBO J."},{"issue":"Pt 3","key":"10.1016\/j.bbrc.2015.04.035_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1113\/jphysiol.1995.sp021090","article-title":"Functional and non-functional isoforms of the human muscle acetylcholine receptor","volume":"489","author":"Newland","year":"1995","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/nar\/21.2.233","article-title":"Differential expression of human nicotinic acetylcholine receptor alpha subunit variants in muscle and non-muscle tissues","volume":"21","author":"Talib","year":"1993","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2015.04.035_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0896-6273(95)90320-8","article-title":"Intersubunit contacts governing assembly of the mammalian nicotinic acetylcholine receptor","volume":"14","author":"Kreienkamp","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2015.04.035_bib8","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1093\/hmg\/ddn305","article-title":"hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome","volume":"17","author":"Masuda","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2015.04.035_bib9","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/srep02931","article-title":"HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA","volume":"3","author":"Rahman","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2015.04.035_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/hmg\/ddp023","article-title":"Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome","volume":"18","author":"Bian","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2015.04.035_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tig.2011.02.004","article-title":"Genetic therapies for RNA mis-splicing diseases","volume":"27","author":"Hammond","year":"2011","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2015.04.035_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2199-8-57","article-title":"Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries","volume":"8","author":"Adams","year":"2007","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.mt.6300095","article-title":"Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript","volume":"15","author":"Wilton","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2015.04.035_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib15","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2015.04.035_bib16","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2015.04.035_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2015.04.035_bib18","doi-asserted-by":"crossref","first-page":"a003707","DOI":"10.1101\/cshperspect.a003707","article-title":"Spliceosome structure and function","volume":"3","author":"Will","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-61779-767-5_6","article-title":"Overview on applications of antisense-mediated exon skipping","volume":"867","author":"van Roon-Mom","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib20","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/humu.22130","article-title":"Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients","volume":"33","author":"Abicht","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbrc.2015.04.035_bib21","doi-asserted-by":"crossref","first-page":"11093","DOI":"10.1073\/pnas.1101135108","article-title":"Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes","volume":"108","author":"Lim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2015.04.035_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1101\/gr.118638.110","article-title":"Loss of exon identity is a common mechanism of human inherited disease","volume":"21","author":"Sterne-Weiler","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2015.04.035_bib23","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1093\/nar\/gku1206","article-title":"In silico prediction of splice-altering single nucleotide variants in the human genome","volume":"42","author":"Jian","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2015.04.035_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1327","article-title":"Genomic variants in exons and introns: identifying the splicing spoilers","volume":"5","author":"Pagani","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2015.04.035_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature09000","article-title":"Deciphering the splicing code","volume":"465","author":"Barash","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.04.035_bib26","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/gb-2013-14-10-r114","article-title":"AVISPA: a web tool for the prediction and analysis of alternative splicing","volume":"14","author":"Barash","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2015.04.035_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.1254806","article-title":"The human splicing code reveals new insights into the genetic determinants of disease","volume":"347","author":"Xiong","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.04.035_bib28","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/bioinformatics\/btr444","article-title":"Bayesian prediction of tissue-regulated splicing using RNA sequence and cellular context","volume":"27","author":"Xiong","year":"2011","journal-title":"Bioinformatics"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15007019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15007019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T12:40:54Z","timestamp":1566564054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15007019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0006291X15007019"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.04.035","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}